Current status of cell-based interventions in Japan
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Genetics,Molecular Medicine
Reference10 articles.
1. Concise review: a comprehensive analysis of reported adverse events in patients receiving unproven stem cell-based interventions;Bauer;Stem Cells Transl. Med.,2018
2. Global distribution of businesses marketing stem cell-based interventions;Berger;Cell Stem Cell,2016
3. Korean deaths spark inquiry;Cyranoski;Nature,2010
4. ASAPS/ASPS position statement on stem cells and fat grafting;Eaves;Plast. Reconstr. Surg.,2012
5. The current status of clinics providing private practice cell therapy in Japan;Fujita;Regen. Med.,2016
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Regulation for the Translation of Gene and Cell Therapy into Medical Practice in East Asian Countries;Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation;2024-02-27
2. Does the Act on the Safety of Regenerative Medicine in Japan ensure “safety”?: Implications of low adverse event reporting;Stem Cell Reports;2023-12
3. Too little, too soon: Japan’s experiment in regenerative medicine deregulation;Cell Stem Cell;2023-07
4. Difficulties in ensuring review quality performed by committees under the Act on the Safety of Regenerative Medicine in Japan;Stem Cell Reports;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3